Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease.
Cristina ChimentiRomina VerardoAndrea FrustaciPublished in: Orphanet journal of rare diseases (2021)
Left ventricular (LV) endomyocardial biopsies from twenty-four females (mean age 53 ± 11 ys) with Fabry disease cardiomyopathy were studied. Diagnosis of FD was based on the presence of pathogenic GLA mutation, Patients were divided in four groups according with LV maximal wall thickness (MWT): group 1 MWT ≤ 10.5 mm, group 2 MWT 10.5-15 mm, group 3 MWT 16-20 mm, group 4 MWT > 20 mm. At histology mosaic of affected and unaffected cardiomyocytes was documented. Unaffected myocytes' size ranged from normal to severe hypertrophy. Hypertrophy of unaffected cardiomyocytes correlated with severity of MWT (p < 0.0001, Sperman r 0,95). Hypertrophy of unaffected myocytes appear to concur to progression and severity of FDCM. It is likely a paracrine role from neighboring affected myocytes.
Keyphrases
- heart failure
- left ventricular
- end stage renal disease
- hypertrophic cardiomyopathy
- ejection fraction
- chronic kidney disease
- replacement therapy
- acute myocardial infarction
- peritoneal dialysis
- prognostic factors
- early onset
- heart rate
- optical coherence tomography
- blood pressure
- mitral valve
- patient reported outcomes
- drug induced
- endothelial cells
- ultrasound guided
- percutaneous coronary intervention
- body composition